LGC Buys Fluidigm BioMark System | GenomeWeb

NEW YORK (GenomeWeb News) — Fluidigm said today that lab services company LGC has purchased a BioMark System for use in its genetic analysis labs in the United Kingdom.

LGC will use the system to enhance its services including digital PCR and gene expression opportunities in its Research & Technology Division. The UK firm also plans to use the system across its other three divisions: LGC Standards, Life & Food Sciences, and LGC Forensics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.